Asparaginase is indeed well known as key in the treatment of acute lymphoblastic leukemia and its potential as “anti-colon cancer protein” has been recently proposed (El-Naggar et al., 2016; Miyo et al., 2016; Toda et al., 2016). The gene discussed is ASPG; the disease is malignant colon neoplasm.